[ Back to EurekAlert! ] Public release date: 20-Aug-2012
[ | E-mail Share Share ]

Contact: Michael Bernstein
m_bernstein@acs.org
215-418-2056 (Philadelphia Press Center, Aug. 17-23)
202-872-6042

Michael Woods
m_woods@acs.org
215-418-2056 (Philadelphia Press Center, Aug. 17-23)
202-872-6293
American Chemical Society


Celebrating the golden anniversary of a remarkable science agency

PHILADELPHIA, Aug. 20, 2012 A gallon of regular gasoline cost 31 cents, a first-class postage stamp 4 cents and an office visit to the doctor's office $5. John F. Kennedy was president. Lawrence of Arabia won the Academy Award for Best Picture. A new band called The Rolling Stones got lots of attention.

It was 1962, and today scientists are gathering here for a special symposium honoring the 50th anniversary of an agency that has improved the health and well-being of millions of people over the last half-century. The event, marking the golden anniversary of the National Institute of General Medical Sciences (NIGMS), is part of the 244th National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society.

"The National Institute of General Medical Sciences has an extraordinary record of achievements that respond to the great challenges facing humanity," said ACS President Bassam Z. Shakhashiri, Ph.D.

The symposium is among several special presidential events being held at the meeting, which continues through Thursday. ACS expects an attendance of 14,000 scientists and others for more than 8,600 reports on new discoveries in science and other topics, plus a major scientific exposition.

"The institute has supported the research of thousands of scientists, and their discoveries are helping society address problems like disease, population growth and malnutrition. We congratulate NIGMS Acting Director Judith H. Greenberg, Ph.D., and its entire staff on this milestone and wish them well for the future."

The Institute also has advanced scientific progress through research training programs that foster the next generation of scientists, including efforts to encourage underrepresented minorities into careers in biomedical research, Shakhashiri added. He pointed out that NIGMS, which is part of the National Institutes of Health, primarily funds research that lays the foundation for advances in disease diagnosis, treatment and prevention. That approach in focusing on what sometimes is termed "basic" research, has paid off in multiple practical discoveries in the prevention, diagnosis and treatment of disease.

###

NIGMS has funded the research of 74 Nobel laureates, including 38 in physiology or medicine and 36 in chemistry. The agency's fiscal 2012 budget of $2.43 billion funds the research of more than 4,700 scientists and 4,300 trainees.

Abstracts of scientific presentations at the symposium appear below.

The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 164,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.

Note to journalists: Please report that this research was presented at a meeting of the American Chemical Society.

Abstracts

Complex molecule synthesis enabling studies at the chemistry/biomedical interface
1. Daniel Romo1 , Professor, PhD, Texas A&M University, Chemistry, Corner of Ross and Spence Sts., P.O. Box 30012, College Station, Texas, 77842-3012, United States , 979-845-9571, 979-862-4880, romo@tamu.edu

Natural products are essential tools for basic cellular studies leading to the identification of medically relevant protein targets and the discovery of potential therapeutic agents. Our total synthesis efforts and synthetic methodology studies are intrinsically coupled to our interests in probing the mode of action of targeted bioactive natural products. In the case of the marine sponge derived natural product, pateamine A, our synthetic and mechanism of action studies in collaboration with Jun Liu's lab (Johns Hopkins) led us to explore eukaryotic protein translation as a therapeutic approach to treat particular cancers that overexpress translation initiation factors and prosurvival proteins as key mechanisms for their uncontrolled proliferation. Our interest in beta-lactone synthesis led us to study novel strategies for inhibition of fatty acid synthase and the proteasome, two therapeutic targets for anticancer chemotherapy in collaboration with Jeff Smith's lab (Sanford-Burnham, La Jolla). In another project, we are studying the chemoselectivity of several reactions to be used as versatile tools for natural product derivatization and bioactive probe synthesis enabling, for example, activity-based protein profiling in collaboration with Ben Cravatt's Lab (Scripps). Selected short stories from these projects performed admirably by graduate/undergraduate students and post-doctoral fellows in my laboratory and generously supported by NIGMS will be described.

Sweet chemical signaling: Understanding the structure-function relationships of carbohydrates in neurobiology and cancer
1. Linda C. Hsieh-Wilson1 , California Institute of Technology, Division of Chemistry and Chemical Engineering and Howard Hughes Medical Institute, 1200 E. California Blvd., Pasadena, CA, 91125, United States , 626-395-6101, lhw@caltech.edu

Carbohydrates comprise one of the largest and most diverse collections of biologically active molecules, and it is increasingly clear that they participate in nearly every aspect of biology. However, relative to their macromolecular peers (i.e., proteins and nucleic acids), carbohydrates remain relatively unexplored, and their structure-function relationships are still poorly understood. Several of the fundamental challenges inherent in studying carbohydrates include: (1) their chemical complexity; (2) the lack of efficient and sensitive analytical methods for their detection and quantification; and (3) their complex chemical synthesis and biosynthesis. We will describe the development of chemical approaches to overcome these fundamental challenges and how the principles and tools of chemistry can be used to uncover new functions for carbohydrates and their associated proteins in neurobiology and cancer.

Advances in palladium-catalyzed oxidation reactions
1. Melanie Sanford1 , 930 N University Ave, Ann Arbor, MI, 48109, United States , 734-615-0451, mssanfor@umich.edu

This presentation will describe the evolution of and recent progress in an NIH-NIGMS supported project in the Sanford group involving the development of new catalytic processes for C-H and olefin oxidation reactions.

Palladium-catalyzed cross-coupling methods for applications in organic synthesis
1. Stephen L. Buchwald1 , Massachusetts Institute of Technology, Chemistry, Department of Chemistry, Room 18-490, Cambridge, Massachusetts, MA, United States , 6172531885, sbuchwal@mit.edu

This talk will describe our work that involves the development of carbon-carbon, carbon-nitrogen, carbon-oxygen and carbon-halogen bond-forming processes of importance for organic synthesis. Our recent progress, applications of the methods and mechanistic studies will be detailed.

Defining the transcriptional initiation interaction network in vivo
1. Anna Mapp1 , Professor, 930 N University Ave, Ann Arbor, MI, 48109, United States , 734-615-6862, amapp@umich.edu

Although it has long been known that proteins called transcriptional activators mediate the assembly of the transcriptional machinery as part of gene up-regulation, it has not been possible to define the direct activator binding events that lead to this assembly. This lack of specific information about activator-transcriptional machinery interactions has been a prominent obstacle in the discovery of pharmacological inhibitors that target particular promoters. To address this we have implemented a site-specific in vivo crosslinking methodology that has enabled the capture and characterization of the direct binding partners of three prototypical transcriptional activators: VP16, Gal4 and Gcn4. These results coupled with transient kinetic data suggest a model in which activators of this class stimulate assembly through a distinct but overlapping set of transient binding interactions. To define the activator-protein interactions targetable for inhibitor development, we have generated small-molecule covalent inhibitors targeted to specific binding surfaces within key coactivators such as CBP.

Backwards and forwards with molecular and classical pharmacology
1. Brian K. Shoichet1 , Professo, PhD, UCSF, Dept. of Pharm. Chem., 1700 4th St., San Francisco, CA, 941582550, United States , 415-514-4126, shoichet@cgl.ucsf.edu

The recent determination of the structures of G-Protein Coupled Receptors enables the structure-based prediction of new ligands for these classic targets. Unbiased docking screens of over 3 Million ZINC library molecules against the 2-Adrenergic, the Adenosine A2a, the Dopamine D3, and the Chemokine CXCR4 receptors, have all returned new scaffolds and sub-micromolar affinity ligands with hit rates ranging from 17 to 35%. The structural, computational and chemical space origins of this hit rate will be discussed, as will opportunities for using homology models of these targets (as done with the D3 receptor), for finding agonists as well as antagonists, and for de-orphanizing GPCRs using a structure-based approach.

In contrast to this molecular biology view of pharmacology, which begins with targets and seeks ligands, the pharmacology practiced in the classical period (~1930 to ~1985) began with ligands and used these to define receptors. As peculiar as this direction of information seems to us, in its day it was highly successful. Here we return to this classic idea, seeking unexpected similarities. Using a chemoinformatic method, we quantitatively compare over 3000 targets to one another based on the similarity of their ligands. The relationships that emerge predict previously unknown off-targets for specific drugs and reagents. Applications to predicting adverse drug reactions, identifying the molecular targets in phenotypic screens, and to understanding the targets underlying mechanism of action will be considered.

Fundamentals of enzymatic transition states and use of the information
1. Vern L Schramm1 , 1300 Morris Park Avenue, Bronx, New York, United States , 718-430-2813, vern.schramm@einstein.yu.edu , 2. Peter C. Tyler2 , 3. Steven D. Schwartz3 ,

Our curiosity about enzymatic transition states led us to develop experimental and computational methods to generate static models of the transition state. The molecular electrostatic potential of the transition state contains sufficient information to provide a blueprint for the design of transition state analogues. Chemical synthesis based on transition state mimicry has provided some of the most powerful enzyme inhibitors known. Transition state analogues against selected targets in this research program have led to several analogues now in human clinical trials. Binding thermodynamics of picomolar and femtomolar transition state analogues with different enzymes show a surprising diversity in sources of binding energy. Crystal structures of enzymes in complexes with transition state analogues provide structural models of enzyme complexes with geometry near the transition state. By comparison with Michaelis complexes, the motions involved in bringing the Michaelis complex to the transition state are revealed. Computational chemistry with starting points from enzyme complexes with transition state analogues provides understanding of transition state lifetimes and protein motions coupled to barrier crossing.

Coupling activities of helicase and polymerase at the DNA replication fork
1. Smita S Patel1 , PhD, Robert Wood Johnson Medical School, Biochemistry, 675 Hoes lane, Piscataway, NJ, United States , 7322353372, patelss@umdnj.edu

DNA replication is catalyzed by the cooperative action of the DNA polymerase, primase, and helicase enzymes. The helicase is a motor protein that uses the energy of NTP hydrolysis to unwind double-stranded DNA and create single-stranded templates for the DNA polymerase to copy. Our studies of phage T7 replication enzymes have shown that the isolated helicase does not efficiently unwind the DNA and its unwinding rate shows a strong dependence on GC-content or DNA stability. The DNA polymerase by itself does not unwind DNA nevertheless it is able to accelerate the helicase through GC-rich regions to enable a uniform rate of DNA synthesis. We are investigating the mechanism of coupling between the helicase and polymerase to understand their cooperative roles at the replication fork. We will discuss recent studies that provide new insights into how the two enzymes are physically and functionally coupled at the replication fork.

Chemistry in living systems
1. Carolyn Bertozzi1 , Prof., University of California, Berkeley, Chemistry and Molecular and Cell Biology, Department of Chemistry, UC Berkeley, Berkeley, CA, 94720, United States , 510-643-1682, 510-643-2628, crb@berkeley.edu

Chemical reactions designed for orthogonality and compatibility with living systems can be harnessed to probe the spatiotemporal dynamics of biopolymers and their various modifications. This talk will focus on recent progress in the development of such bioorthogonal reactions and their applications toward profiling protein glycosylation dynamics associated with development and disease. This research, supported largely by NIGMS, highlights the synergies of "curiosity-driven" and "applications-driven" (i.e., translational) science.

Inorganic chemistry controlling cellular physiology and development
1. Tom O'Halloran1 , Silverman 4611, Evanston, IL, United States , 847-491-5060, t-ohalloran@northwestern.edu

Cells must acquire a variety of transition metal ions until they achieve a highly conserved ensemble of metal concentrations known as the metallome. While highly conserved over evolution, metallomes undergo temporal fluxes in pathogenesis, during cellular proliferation and at the earliest stage of development. Metallomes are controlled by metalloregulatory proteins, which sense changes in metal availability and adjust gene expression accordingly. Structural and thermodynamic studies of these metal receptors are providing new insights into the coordination chemistry and allosteric mechanisms that give rise to extreme sensitivity (i.e., zinc changes in femtomolar range and copper in zeptomolar range). Quantitative physical methods (STEM-EDS, ICP-MS, X-ray fluorescence microscopy and fluorescent metal-specific probes) reveal connections between fluxes in subcellular metals and key cellular decisions such as cell cycle entry and exit. New examples where metal fluxes trigger physiological change will be described including those controlling the earliest stage of mammalian development and infectious disease.



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.